Rockville-based Emergent BioSolutions will expand its Baltimore manufacturing facility and add 158 new jobs over the next four years. Emergent will potentially double its 58,000-square-foot space on Lombard Street to include additional manufacturing, labs and warehouse space.
After growing up on Cleveland’s east side, Bill Fuller headed for North Carolina in 1990. He returned briefly in the 2000s, but he didn’t think he’d ever come back. But when BioEnterprise asked him in 2013 to become its newest CEO-in-Residence, he couldn’t resist the opportunity.
In Palo Alto in the heart of Silicon Valley, hedge fund manager Joon Yun is doing a back-of-the-envelope calculation. According to US social security data, he says, the probability of a 25-year-old dying before their 26th birthday is 0.1%. If we could keep that risk constant throughout life instead of it rising due to age-related disease, the average person would – statistically speaking – live 1,000 years. Yun finds the prospect tantalising and even believable. Late last year he launched a $1m prize challenging scientists to “hack the code of life” and push human lifespan past its apparent maximum of about 120 years (the longest known/confirmed lifespan was 122 years).
Maryland is giving biotech firm Emergent BioSolutions a $2 million loan to double its footprint and staff in East Baltimore.
Emergent BioSolutions, which develops vaccines and other pharmaceuticals, will double its 58,000-square-foot manufacturing facility on Lombard Street to include more space for manufacturing, quality control cabs and warehouse space. Emergent expects to break ground on the expansion in the second quarter of 2015.
A new 30,000-square-foot business incubator planned for Johns Hopkins University’s East Baltimore campus will more than double the university’s capacity for startup companies and is a major step toward its goal of being a bigger player in technology commercialization.
The new incubator, called FastForward East, will be housed at 1812 Ashland Ave., a 170,000-square-foot building by Forest City Enterprises, Inc. The building will be the next to go up in Hopkins’ Science + Technology Park, which is part of the 88 acre East Baltimore Development, Inc. project, for which Forest City is the master developer. Construction is expected to be complete in 2016.
The six startups that make up the new class of DreamIt Health Baltimore got to work Friday, Jan. 30. Along with offering the first chance for founders to get to know each other through icebreaker games, the orientation marked the first work session at a new coworking space in Power Plant Live.
States with robust innovation economies have assets in common: a corps of research-intensive universities, a highly educated workforce and a government supportive of their science and technology industries. Maryland has all of these things. What the state needs to strengthen is its entrepreneurial culture, so that it becomes a top destination for scientists serious about ushering their ideas out of the lab and into the marketplac
The 3rd annual Ag Biotech Entrepreneurial Showcase is on May 19, 2015 in Research Triangle Park, NC. Ten to twelve entrepreneurs from across the greater eastern U.S. will be selected, and cash prizes for the best presentations will be awarded.
The deadline to submit an Application to present is February 12.
Francis S. Collins, M.D., Ph.D., and Harold Varmus, M.D.
President Obama has long expressed a strong conviction that science offers great potential for improving health. Now, the President has announced a research initiative that aims to accelerate progress toward a new era of precision medicine (www.whitehouse.gov/precisionmedicine). We believe that the time is right for this visionary initiative, and the National Institutes of Health (NIH) and other partners will work to achieve this vision.
Perceptive Navigation, a medical device start-up company whose chief executive is Johns Hopkins cardiologist Dr. Ted Abraham, won a highly competitive Small Business Innovation Research (SBIR) Phase 2 grant. Perceptive Navigation, located at the Johns Hopkins University Montgomery County Campus, works to commercialize the Vu-Cath, an image-guided catheter that can be used in complex surgeries. The device, which is on a needle, is used while doing medical procedures on small areas of the body.
